Pharmacology Quiz on Therapeutic Index and Dosage
48 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What does the Therapeutic Index (TI) indicate about a drug?

  • The speed at which the drug is metabolized.
  • The potential effectiveness and safety of the drug. (correct)
  • The time required for the drug to take effect.
  • The likelihood of drug addiction.
  • How is the Therapeutic Index calculated?

  • TI = LD50 + ED50
  • TI = ED99 / LD1
  • TI = ED50 - LD50
  • TI = LD50 / ED50 (correct)
  • Which of the following factors does NOT modify the dosage and action of drugs?

  • Gender
  • Weather conditions (correct)
  • Age
  • Genes
  • What is the Median Lethal Dose (LD50) primarily used to determine?

    <p>The dose required to kill 50% of a test population.</p> Signup and view all the answers

    What is the risk-benefit ratio used to assess?

    <p>The estimated harm versus expected advantages of drug use.</p> Signup and view all the answers

    If a patient has a Body Weight (BW) of 140 kg, how would their individual dose be calculated based on the average adult dose?

    <p>Individual dose = 140/70 × average adult dose.</p> Signup and view all the answers

    Which of the following is NOT a method to understand the dose-response relationship?

    <p>Combination therapy response.</p> Signup and view all the answers

    What does the Margin of Safety measure?

    <p>LD1/ED99.</p> Signup and view all the answers

    What effect does urine pH have on the clearance of weak bases?

    <p>Weak bases ionize more and are less reabsorbed in alkaline urine.</p> Signup and view all the answers

    Which of the following substances is primarily excreted through the lungs?

    <p>Alcohol</p> Signup and view all the answers

    What happens to drugs that undergo enterohepatic cycling after being excreted into the bile?

    <p>They can be reabsorbed into the portal vein.</p> Signup and view all the answers

    Which of the following drugs can darken stool color?

    <p>Ferrous sulfate</p> Signup and view all the answers

    In which order of kinetics does the rate of drug elimination remain constant irrespective of drug concentration?

    <p>Zero-order kinetics</p> Signup and view all the answers

    Which type of drugs is likely to be harmful to breastfeeding infants due to excretion in breast milk?

    <p>Opioids like Codeine</p> Signup and view all the answers

    What is a characteristic of first-order kinetics in drug elimination?

    <p>Elimination rate varies based on drug concentration.</p> Signup and view all the answers

    What type of substances are likely to be excreted in sweat?

    <p>Metalloids and certain antibiotics</p> Signup and view all the answers

    What factor is crucial for the effect of drugs on cells or tissues?

    <p>Drug binding specificity</p> Signup and view all the answers

    What is a common consequence of higher drug doses?

    <p>Side effects from alternate targets</p> Signup and view all the answers

    How do drugs typically interact with ion channels?

    <p>By binding to receptor sites or other parts of the channel</p> Signup and view all the answers

    What type of ion channels open in response to cell polarization?

    <p>Voltage-gated ion channels</p> Signup and view all the answers

    What role do carrier molecules play in drug action?

    <p>Transporting ions and small organic molecules across membranes</p> Signup and view all the answers

    Which drug is known to inhibit the angiotensin-converting enzyme?

    <p>Enalapril</p> Signup and view all the answers

    What type of proteins do most drugs bind to for effect?

    <p>Common protein molecules like enzymes and receptors</p> Signup and view all the answers

    What is an example of a drug that functions by inhibiting a proton pump?

    <p>Omeprazole</p> Signup and view all the answers

    What is the primary role of a receptor in drug interactions?

    <p>To receive chemical signals from outside a cell</p> Signup and view all the answers

    Which of the following statements about drug-receptor interaction is true?

    <p>Drugs can only modify ongoing cellular functions</p> Signup and view all the answers

    What is the main site for drug metabolism in the body?

    <p>Liver</p> Signup and view all the answers

    What is the difference between potency and efficacy in the context of drugs?

    <p>Potency is the amount of drug required for effect, whereas efficacy describes the ability to produce an effect</p> Signup and view all the answers

    Which of the following represents a pro-drug that is activated through metabolism?

    <p>Sulindac</p> Signup and view all the answers

    Which concept emphasizes the relationship between the concentration of a drug and its response?

    <p>Dose-response relationship</p> Signup and view all the answers

    Which type of reaction is categorized as a Phase 1 biotransformation?

    <p>Oxidation</p> Signup and view all the answers

    What defines the maximal efficacy of a drug?

    <p>The largest effect that a drug can produce</p> Signup and view all the answers

    What is the primary purpose of drug metabolism?

    <p>To transform lipophilic drugs into more polar excretable products</p> Signup and view all the answers

    What does the term 'intrinsic activity' refer to in pharmacology?

    <p>The degree to which a drug can induce effects at its receptor</p> Signup and view all the answers

    What is not a function of Phase 1 reactions in drug metabolism?

    <p>Conjugation with endogenous substances</p> Signup and view all the answers

    Which theory suggests that drug response depends on the proportion of receptors occupied by drugs?

    <p>Occupation theory</p> Signup and view all the answers

    Which enzyme system is primarily responsible for catalyzing oxidation in Phase 1 reactions?

    <p>Cytochrome P-450 mono-oxygenase</p> Signup and view all the answers

    Which of the following is NOT a correct characteristic of receptors?

    <p>They can impart entirely new cell functions</p> Signup and view all the answers

    Which of the following is a characteristic of Phase 2 biotransformation reactions?

    <p>They involve conjugation with endogenous substances.</p> Signup and view all the answers

    Which of the following drugs undergoes biotransformation to form an active metabolite?

    <p>Amitriptyline</p> Signup and view all the answers

    What is the primary role of cytochrome P-450 mono-oxygenase?

    <p>Catalysis of drug metabolism</p> Signup and view all the answers

    Which of the following factors can influence drug metabolism?

    <p>Age</p> Signup and view all the answers

    Which is a consequence of enzyme induction by certain drugs?

    <p>Increased biotransformation of drugs</p> Signup and view all the answers

    Which CYP isozyme is NOT among the six isozymes responsible for most P450-catalyzed reactions?

    <p>CYP1A1</p> Signup and view all the answers

    What type of reactions are most cytochrome P-450 enzymes involved in?

    <p>Phase I reactions</p> Signup and view all the answers

    Which of the following conditions may require enzyme induction for treatment?

    <p>Congenital non-haemolytic jaundice</p> Signup and view all the answers

    What effect can an active metabolite have on drug activity?

    <p>Enhance drug action</p> Signup and view all the answers

    Which of the following is NOT a physiological factor that can depress microsomal enzyme systems?

    <p>Increased hydration</p> Signup and view all the answers

    Study Notes

    Drug Metabolism/Biotransformation

    • Enzymatically mediated alteration in drug structure
    • Transforms lipophilic drugs into more polar, excretable products (inactivation)
    • Essentially, metabolism is a mechanism of drug elimination, leading to:
      • Reduced lipid solubility - increased polarity.
      • Reduced biological activity.

    Main Site - Liver

    • Major site for drug metabolism, but specific drugs may undergo biotransformation in other tissues like the kidney, intestines, and skin (minor).
    • Biotransformation is catalyzed by specific enzymes (hepatic microsomal systems), which also catalyze the metabolism of endogenous substances (e.g., steroids).
    • Some agents are initially administered as inactive compounds (prodrugs) and require metabolism to their active forms.

    Metabolism May Results

    • Active & More Active Metabolite:
      • Chloroquine → Hydroxychloroquine
      • Amitriptyline → Nortriptyline
      • Diazepam → Oxazepam
    • Activation of Inactive Drugs:
      • Sulindac → Sulindac sulfide
      • Enalapril → Enalaprilat
    • Inactivation of Drugs:
      • Propranolol
      • Lidocaine

    Phases of Biotransformation Reactions

    • Phase 1 (Non-synthetic reactions)
    • Phase 2 (Synthetic reactions)

    Phase 1 (Non-synthetic reactions)

    • Involve enzyme-catalyzed biotransformation of the drug without any conjugations.
    • Includes oxidations, reductions, and hydrolysis reactions.
    • Introduce a functional group (e.g., OH, -COOH, -SH, -NH2) which serves as an active site for conjugation in phase II reactions.
    • Examples of enzymes include:
      • Cytochrome P-450 mono-oxygenase system (mixed-function oxidase)
      • Aldehyde/alcohol dehydrogenase
      • Aldehyde dehydrogenase
      • Deaminase
      • Esterase
      • Amidases
      • Epoxide hydratases

    Phase II (Synthetic) reactions

    • Conjugation reactions involving enzyme-catalyzed combination of a drug (or metabolite) with an endogenous substance (e.g., glucuronide, sulfate, amino acids, glutathione, methyl groups, acetyl groups, etc.).
    • Enzymes used in phase II reactions include:
      • Glucoronyl transferase (glucuronide conjugation)
      • Sulfotransferase (sulfate conjugation)
      • Transacylase (amino acid conjugation)
      • Acetylases
      • Ethylases
      • Methylases

    Cytochrome P-450 Mono-oxygenase/Mixed Function Oxidase

    • Primarily located in the liver.
    • Plays a vital role in drug metabolism.
    • Large variety of P-450 exists, each catalyzing metabolism of a unique spectrum of drugs with some overlaps in substrate specificities.
    • Six isozymes responsible for the vast majority of P-450-catalyzed reactions: CYP3A4, CYP2D6, CYP2C9/10, CYP2C19, CYP2E1, and CYP1A2.
    • Most involved in phase I reactions
    • Catalyses reactions such as aromatic & aliphatic hydroxylation, dealkylations at nitrogen, sulfur, & oxygen atoms, heteroatom oxidations at nitrogen, sulfur atoms and reductions at nitrogen atoms.

    Factors that Influence Metabolism

    • Physiological Factors: starvation, obstructive jaundice, liver diseases, cardiovascular problems.
      • These depress microsomal enzyme systems.
    • Age: people in extreme ages (young/elderly) have decreased metabolism due to immature/degenerative enzyme systems.
    • Genetically determined differences: variations in acetylation (e.g., isoniazid, procainamide, hydralazine) can lead to drug toxicity.
    • Prior administration of other drugs: Repeated administration can induce or inhibit microsomal enzymes.

    Inducers

    • Cytochrome P450 enzymes are an important target for pharmacokinetic drug interactions.
    • Drugs like phenobarbital, rifampin, and carbamazepine increase the synthesis of one or more CYP isozymes.
    • This results in increased drug biotransformation, leading to:
      • Decreased plasma drug concentrations.
      • Decreased drug activity (if metabolite is inactive).
      • Increased drug activity (if metabolite is active).
      • Decreased therapeutic drug effects.

    Possible Uses of Enzyme Induction

    • Congenital non-haemolytic jaundice: phenobarbitone hastens bilirubin clearance.
    • Cushing's syndrome: phenytoin reduces steroid degradation.
    • Chronic poisonings: faster metabolism of accumulated substances.
    • Liver disease: drug elimination is often affected.

    Inhibitors

    • Inhibition of CYP isozyme activity is another source of drug interactions leading to adverse effects.
    • Inhibition is often through competition. For example, omeprazole inhibits CYP isozymes responsible for warfarin metabolism. Increase in warfarin concentrations increase risk of bleeding.
    • CYP inhibitors include erythromycin, cimetidine, ketoconazole, and ritonavir.

    Onset of Effect

    • Inhibitors: enzyme inhibition is fast (within hours).
    • Inducers: induction takes 4-14 days to reach a peak, and is maintained while the inducing agent is given, then returns to original value over 1-3 weeks.

    Drug Excretion

    • Removal of a drug from the body.
    • Major routes include renal excretion, hepatobiliary excretion, and pulmonary excretion.
    • Minor routes include saliva, sweat, tears, breast milk, vaginal fluid, and hair.
    • Rate of excretion influences duration of drug action.
      • Slow excretion leads to prolonged drug actions.

    Routes of Drug Excretion (Renal)

    • For water-soluble & non-volatile drugs
    • Processes include:
      • Glomerular filtration
      • Active tubular secretion
      • Passive tubular reabsorption
    • Glomerular filtration and active tubular secretion removes drug; passive tubular reabsorption retains the drug.

    Various Factors influencing Renal Clearance of Drugs

    • Age: decreased glomerular filtration rate in older adults affects drug excretion.
    • Genetics: variations in tubular secretion processes influence drug action duration. (e.g., penicillin, aspirin, cephalosporin)
    • Urine pH: ionization of weak acids/bases influence absorption in urine.
      • Weak bases less reabsorbed in acidic urine.
      • Weak acids less reabsorbed in alkaline urine.

    Hepatobiliary Excretion

    • Conjugated drugs are excreted by hepatocytes into bile.
    • Some drugs may undergo enterohepatic cycling (reabsorption into portal vein) prolonging drug action.
    • Examples include chloramphenicol and estrogen.

    Gastrointestinal Excretion

    • Drugs not absorbed during oral administration are excreted in the feces.
    • Drugs that do not undergo enterohepatic cycling appear in the stool.
    • Examples include aluminum hydroxide (white stool color), ferrous sulfate (darkens stool), and rifampicin (orange-red stool).

    Pulmonary Excretion

    • Many inhalation anesthetics and alcohol are excreted via the lungs.

    Sweat Excretion

    • Rifampicin and metalloids (e.g. arsenic) are excreted via the sweat glands.

    Mammary excretion

    • Many drugs, including Ampicillin, Aspirin, Chlorodizepoxide, and Streptomycin, can be excreted into breast milk.
    • Lactating mothers should exercise caution regarding drug intake

    Kinetics of Elimination

    • Quantitative aspects of renal drug elimination.
    • Elimination occurs in two orders:
      • First-order kinetics: majority of drugs are eliminated through this, the rate of elimination is directly proportional to the drug concentration (clearance remains constant). - However, with high enough dose, elimination pathways of all drugs saturate.
      • Zero-order kinetics: some drugs' elimination kinetics change to zero/higher-order kinetics when drug concentration is constant, meaning a constant amount of drug is eliminated in a set time, while clearance decreases with increasing concentration.

    Cont'd... (Elimination/Excretion Rate)

    • Excretion rate = clearance × plasma concentration
    • Extraction ratio = decline of drug concentration in the plasma from arterial to venous side of the kidney (= c2/c1)
    • Clearance (mg/ml) = excretion rate (mg/min)/Cp
    • Total body clearance: sum of clearances of various drug metabolizing & drug eliminating organs.
      • CLtotal = CLhepatic + CLrenal + CLpulmonary + CLother
    •   Not possible so CLtotal = k_v*Vd

    Kinetics of Following Dosage Forms (Home Exercise)

    • Kinetics of IV infusion
    • Kinetics of fixed-dose/fixed-time-interval regimens.

    Half-life

    • Time required for the drug concentration to reduce by one-half.
    • Plasma half-life depends on how quickly the drug is eliminated from the plasma.

    Adjustment in Dosage

    • T1/2 (half-life) increases/decreases due to various factors:

      • diminished renal/hepatic blood flow/extraction ratio or decreased metabolism, or increased protein binding.
      • increased hepatic blood flow, decreased protein binding, increased metabolism.

    Therapeutic Drug Monitoring

    • Plasma concentration of drug during treatment essential in:
      • Drugs with low safety margins (e.g., digoxin, lithium, cyclosporine)
      • Individual variations
      • Presence of renal failure
      • Poisoning cases
      • Failure of response

    Pharmacodynamics

    • Mechanisms of drug actions:
      • How drugs act in the body
      • Effects (beneficial and harmful)
      • What drugs do in the body.
    • Important note: Drugs modify physiological activity but don't confer new functions on tissues. Drug molecules are few compared to tissue molecules for effects to be significant.

    Drug Specificity

    • Drug specificity is important but no drug is completely specific in its actions.
      • At higher doses, some drugs can affect multiple targets leading to side effects.
      • Example: TCAs block amine pump reuptake but also affect acetylcholine receptors.
    • Most drugs produce effects by binding to protein molecules (enzymes, carrier molecules, ion channels, receptors).

    Enzyme (Pharmacodynamics) Example

    • Angiotensin converting enzyme is inhibited by enalapril to reduce angiotensin II formation, leading to vasodilation.

    Ion Channels (Pharmacodynamics)

    • Protein molecules form water-filled pores spanning cell membranes, switching between open and closed states.
    • Ligand-gated ion channels open upon agonist binding.
    • Voltage-gated ion channels (e.g., Na+, K+, Ca++) open with membrane polarization.
    • Drugs may alter channel function directly binding to receptors, or indirectly via intermediaries.

    Carrier Molecules (Pharmacodynamics)

    • Proteins for ion/small molecule transport across cell membranes.
      • Examples include renal tubular transport, uptake of neurotransmitter precursors, and effects on C proteins.

    Receptor (Pharmacodynamics)

    • Protein molecules that receive chemical signals from outside the cell, situated either at the cell surface or inside the cell for drug action.
      • Drug + Receptor= Drug-Receptor complex for action
    • Non-receptor mechanisms operate through simple physical/chemical reactions (e.g., antacids neutralizing).

    Types of Receptors (Diagram)

    • Ligand-gated ion channels (e.g., cholinergic receptors)
    • G protein-coupled receptors (e.g., adrenergic receptors)
    • Enzyme-linked receptors (e.g., insulin receptors)
    • Intracellular receptors (e.g., steroid receptors)

    Intracellular Receptor (Pharmacodynamics)

    • Lipid-soluble drugs diffuse across cell membranes and move to the nucleus.
    • Drugs bind to intracellular receptors, forming a drug-receptor complex.
    • The complex binds to chromatin activating gene transcription thus producing specific proteins to cause biologic effect.

    Induced Fit Model (Pharmacodynamics/Kinetics)

    • Binding of a substrate to an enzyme is accompanied by a significant change in the enzyme's active site structure.

    Different Theories Involved

    - Lock-and-key
    - Rate theory
    - Occupation theory
    - Resting state model
    - Activated state model
    

    Implications of Drug-receptor Interaction

    • Drugs alter the rate of bodily functions
    • Drugs cannot create new functions for cells
    • Drugs only modify ongoing effects, not create them
    • Effects can occur beyond normal physiological ranges.

    Three Aspects of Drug Receptor Function

    • Receptors determine the quantitative relationship between drug concentration and response, based on affinity and abundance in target cells.
    • Receptors as complex molecules that function as regulatory proteins in chemical signalling pathways.
    • Receptors determine the therapeutic and toxic effects of drugs.

    Dose-Response Relationship

    • Dose: amount of drug required to produce a desired response in an individual.
    • Dosage: frequency, amount, and duration of drug administration.
    • Potency: measure of how much drug is required to elicit a given response, less dose more potent.
    • Efficacy: inherent ability of a drug to produce an effect at receptors
    • Maximal efficacy: greatest effect attainable by a drug.
    • Drug response depends on affinity of drug for the receptor and intrinsic/inherent activity.

    Agonism and Antagonism

    - Agonists facilitate receptor response (keys in a lock).
    - Antagonists inhibit receptor response (blocks the lock).
    

    Types of Drug-Receptor Interactions

    • Agonists: bind to and activate receptors to produce effects. Some inhibit their binding proteins to terminate effect (e.g. cholinesterase inhibitors).
      • Example: stopping the breakdown of acetylcholine.
    • Antagonists: bind to receptors but lack intrinsic activity; prevent other molecules from binding.
      • Example: atropine decreasing acetylcholine effects

    Partial Agonists and Inverse Agonists

    • Partial agonists: act as agonist or antagonist, depending on circumstances; lower maximal efficacy, e.g., pindolol.
    • Inverse agonists: produce an effect opposite to that of an agonist by occupying the same receptor, e.g. metoprolol.

    Graded Dose-Response Relations

    • As drug concentration increases, its pharmacological effect also increases up to maximum effect (when all receptors are occupied).
    • Used to determine affinity, potency, efficacy, and characteristics of antagonists.

    Potency

    • Effective concentration (EC50): concentration of agonist needed to produce half the maximum biological response.
    • Potency of an agonist is inversely related to its EC50 value. (The lower the EC50, the higher the potency.)
    • Higher potency leads to the leftward shift of the DRC (Dose Response Curve).

    Efficacy

    • Maximum possible effect relative to other agents
    • Determined by the peak (highest level) of the DRC
    • Full agonist = 100% effect
    • Partial agonist = 50% effect
    • Antagonist = 0% effect.
    • Inverse agonist = - 100%

    Quantal (Cumulative) Dose-Response Relationship

    • Relationship between the dose of a drug and the proportion of a population that responds to it (all or none).
    • Useful for determining doses where most of the population responds.
    • Examples: ED50%, TD50%, LD50%, therapeutic index (TI), inter individual variability

    Therapeutic Index

    • Indicator of drug effectiveness and safety
    • Ratio of lethal dose (LD50) to effective dose (ED50), smaller TI is less safe.
      • Margin of safety = LD 1 / ED 99 is another metric.

    Risk-Benefit Ratio

    • Weighing harm (side effects, cost, inconvenience) against benefits (relief, cure, quality of life), difficult to quantify.
    • Clinicians rely on data from large populations and their own experience.

    Factors Modifying Drug Dosages & Actions

    - Age, sex/species
    - Weight and size
    - Genetics
    - Route of administration/food/drug-drug interactions
    - Physiological state (e.g., pregnancy)
    - Disease state/pathology
    - Tolerance, natural/acquired
    - Psychological factors
    

    Dosage Calculation

    - Methods for calculating individual dosages (e.g., Young's rule, Clark's rule, and Fried's rule).
    

    Drug-Drug Interactions

    • Consequences:
      • Additive Effects: similar intrinsic activity with combined effects.
      • Synergism: combined drugs have a greater effects than separate effects.
      • Potentiation: one substance has no effect alone but increases another's effectiveness.
      • Reduction of Effects: diminished beneficial/increased detrimental effect caused by antagonism.

    Types of Antagonism

    . Chemical: Drug binding . Physical: Drug-property based, e.g. charcoal binding alkaloids . Receptor Block: Drugs binding to receptor sites.
    . Competitive: In equilibrium; antagonists compete with agonists for receptor sites. . Non-competitive: Binding not in equilibrium; binds and alters the receptor/binding molecule irreversibly. . Physiological/Functional: Opposing effects from two drugs.

    Basic Mechanisms of Drug-Drug Interactions

    • Drug interactions can result from direct chemical/physical mixing effects or by altering pharmacokinetic features (absorption, distribution, metabolism, excretion. ) or pharmacodynamic features (receptor binding)

    Drug-Food Interactions

    • Impact on drug: -Absorption (can decrease or increase it). -Metabolism (grapefruit juice effect). -Toxicity (e.g., MAOIs and tyramine). -Action (e.g., vitamin K and warfarin).

    Adverse Drug Reactions (ADRs)

    • Any undesirable response a drug might create.
    • Types:

    • Augmentative (side effects)

    • Bizarre (allergic, idiosyncratic)

    • Chronic (cumulative effects)

    • Delayed (teratogenic)

    • End-of-use (withdrawal)

    Cont'd... (ADRs)

    • Side Effects: unavoidable secondary drug effects produced even at therapeutic doses (e.g., drowsiness from antihistamines, gastric bleeding from aspirin)
    • Toxicities: adverse reactions caused by excessive drug levels (e.g. morphine overdose coma.)
    • Allergic Reactions (type I to IV) occur in immune-sensitive individuals, re-exposure can lead to stronger responses.

    Cont'd... (ADRS): Idiosyncratic/Physical/Carcinogenic Effects

    • Idiosyncratic: unusual response due to predisposition.
    • Physical dependence, e.g., withdrawal when certain drugs are discontinued, during long-term use (opioids, barbiturates).
    • Carcinogenicity: some mediators/chemicals cause cancer. Even though numerous compounds have been identified, few are therapeutically used.
    • Iatrogenic Effects: unwanted responses during treatment, e.g., dermatological reactions, hepatic toxicity, Cushing's syndrome and teratogenic effects.
    • Teratogenic effects: drug-induced birth defects.

    G Protein-Coupled Receptors (GPCRs)

    • Receptors that interact with G proteins (e.g., Gs, Gq, Gi).
    • Different G-protein types and associated receptors signal the stimulation of different intracellular pathways.
      • The different pathways that signal through respective G proteins initiate different downstream effects / result in different physiological response.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Pharmaco-Kinetics 2 PDF

    Description

    This quiz tests your knowledge on key pharmacology concepts such as Therapeutic Index, Median Lethal Dose, and the risk-benefit ratio. You'll also explore how factors modify drug dosage and the methods used to understand dose-response relationships. Perfect for students and professionals in the field of pharmacology.

    More Like This

    Use Quizgecko on...
    Browser
    Browser